Vineet Laboratories Limited

Web: vineetlabs.co.in NSE: VINEETLAB BSE: 543298 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

37 0(0%)

Volume

10k as on 23, Jun

Open

58

High

61

Low

58

Close

38

VWAP

34

52 Week High

44

52 Week Low

27

Viand Research Rating
Quality Score

25/100

Growth Score

10/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

72

No. of Shares

1.92

P/E

-12.13

P/B

1.43

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

-11.81

ROCE

-

Profit Growth

-

Listing Date

15-Jun-21

Promoter Holding

5.98%

FII Holding

0.36%

DII Holding

-

Price Chart
Price Performance
1 Week3%
1 Month5%
3 Months11%
6 Months11%
1 Year0%
YTD11%
Moving Average
5 Day SMA35
10 Day SMA34
20 Day SMA34
30 Day SMA35
50 Day SMA35
61 Day SMA0
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 336353637
Resistance 236353536
Resistance 135353535
Pivot Point35353535
Support 134353434
Support 233353434
Support 333343333
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,56,65518990%2%9%21%3757.70.0711509
2DIVISLAB2,43,19691612%8%44%51%6957.702568
3TORNTPHARM1,84,30348462%3%12%36%7257.71.792138
4APOLLOHOSP1,24,83486501%1%12%10%5857.70.92003
5ZYDUSLIFE1,12,89711324%2%26%13%2057.70.465124
6CIPLA1,11,34613852%5%3%12%2257.70.023862
7LAURUSLABS99,63418443%3%75%114%057.70.48890
8DRREDDY96,96211512%2%11%8%2057.70.24158
9MAXHEALTH96,6469851%10%8%14%057.70.321442
10LUPIN96,62021131%11%8%10%2357.70.295355
Load More
Shareholding Pattern (%)
Mar 2026Feb 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 5.98%(-6.51) 5.98%(-3.41) 12.46%(-13.41) 15.89%(-6.61) 29.26%(0.01) 35.85%(-0.21) 35.85%(-1.41) 36.07%(0.01) 37.50%(0.01) 37.50%(-1.11) 37.55%(0.01) 38.66%(0.01) 38.66%(2.71) 38.66%(0.01) 35.96%(0.01) 35.96%(0.01) 35.96%(0.01) 35.96%(0.01) 35.96%(0.01) 35.96%
FIIs(0.41) 0.36%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(-0.21) 0.00%(0.21) 0.24%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
Public93.67%94.02%87.54%84.11%70.74%64.15%64.15%63.93%62.49%62.50%62.20%61.34%61.34%61.35%64.03%64.04%64.04%64.04%64.04%64.04%
No. of Shareholders9,92910,04210,0039,6829,98810,02510,05810,3009,5239,6389,5149,4699,3069,8219,5279,4369,5789,1649,1599,216
Quarterly Results
Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Sales15.6517.427.4414.0818.118.9623.8637.0532.6543.3737.5257.266.7639.5148.825638.3639.55
Sales Growth % (YoY)-13.5%-8.1%-68.8%-62%-44.6%-56.3%-36.4%-35.2%-51.1%9.8%-23.2%2.9%74%-0.1%--77%--
Sales Growth % (QoQ)-10.2%134.1%-47.2%-22.2%-4.5%-20.5%-35.6%13.5%-24.7%15.6%-34.4%-14.3%69%-19.1%-12.8%46%-3%-
Expenses13.1714.247.1325.1222.2319.2724.6533.6333.2939.237.2651.3964.8143.5244.95035.7237.74
Operating Profit2.483.180.31-11.04-4.13-0.31-0.793.42-0.644.170.265.811.95-4.013.9262.641.81
OPM %15.8518.254.17-78.41-22.82-1.64-3.319.23-1.969.610.6910.162.92-10.158.03116.884.58
Other Income0.050.010.021.380.030.20.370.410.010.010.030.03000.080-0.010.16
Interest1.092.190.610.90.950.991.141.721.081.020.960.371.030.611.3710.350.49
Depreciation0.630.630.630.660.620.620.610.670.630.610.610.620.510.70.5410.50.5
Profit before tax0.810.37-0.91-11.22-5.67-1.72-2.171.44-2.342.55-1.284.850.41-5.322.0951.780.98
Tax %-3.7-8.11-4.4-6.240.536.98-1.84-34.03-11.114.71-2.3426.8-239.02-11.8451.673223.625.51
Net Profit 0.850.4-0.87-10.53-5.71-1.83-2.131.92-2.072.42-1.253.551.39-4.71.0131.360.72
Net Profit Growth % (QoQ)112.5%146%91.7%-84.4%-212%14.1%-210.9%192.8%-185.5%293.6%-135.2%155.4%129.6%-565.3%-66.3%120.6%88.9%-
Net Profit Growth % (YoY)114.9%121.9%59.2%-648.4%-175.8%-175.6%-70.4%-45.9%-248.9%151.5%-223.8%18.3%2.2%-752.8%----
TTM Net Profit-10.15-16.71-18.94-20.2-7.75-4.110.141.022.656.11-1.011.250.6999999999999990.676.095.082.080
EPS in Rs0.440.21-0.45-5.48-2.97-0.95-1.111-1.081.26-0.651.850.72-2.451.13.561.480.78
Profit and Loss
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Sales751512121912430
Sales Growth %-50%-29%11%-22%--
Expenses911432051782350
Operating Profit-16781380
OPM %-2254730
Other Income200000
Interest453230
Depreciation232220
Profit before tax-2102940
Tax %-3-1833829560
Net Profit -2011720
Net Profit Growth %-2100%--85.7%250%--
EPS in Rs-10.520.540.653.460.93-0.11
Dividend Payout %0001400
Cash Flows
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Cash from Operating Activity11-7-108270
Cash from Investing Activity-3-2-7-4-80
Cash from Financing Activity-88012190
Net Cash Flow00-1616380
Balance Sheet
Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Equity Capital999.2299990.41
Reserves5521.55262424170
Borrowings434040.57443127120
Other Liabilities344035.19385174700
Total Liabilities9195106.531171161331090
Fixed Assets242526.35272721200
CWIP00000000
Investments000.2300000
Other Assets666979.959089112890
Total Assets9195106.531171161331090
Delivery

Delivery Data: VINEETLAB

#Date
35
14%
40
Value (Cr)Q/T
320
Del
59
Del
1
14-Sep37
0
137700
23-Sep38
0
169590
32-Sep38
0
113370
41-Sep38
1
527821
531-Aug39
1
315791
628-Aug39
0
71510
727-Aug39
0
111290
826-Aug39
0
113570
925-Aug39
0
233760
1024-Aug37
0
213720
1121-Aug38
1
601911
1220-Aug38
0
97500
1319-Aug38
0
103520
1418-Aug36
1
241360
1517-Aug37
0
251280
1614-Aug37
0
144800
1713-Aug38
0
39780
1812-Aug39
0
262860
1911-Aug37
0
262870
Daily Market Cap
DateTotal Market CapChangeChg %
04-Sep72c98L1.35
03-Sep73c5c6.98
10-Aug68c3c4.32
07-Aug71c4c5.13
06-Aug75c77L1.04
05-Aug74c19L0.26
04-Aug74c2c2.01
03-Aug76c86L1.13
31-Jul76c46L0.61
30-Jul76c67L0.88
29-Jul77c2c2.18
28-Jul75c23L0.31
27-Jul75c54L0.73
24-Jul74c00
Stock Checklist
Price is above from 52 week high low average: 63%
Stock is trading above all short term SMAs: YES
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0